LeonaBio, Inc. (LONA) Key Metrics
LONA valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $49.0M
- Enterprise value
- $5.0M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 1.7 10-yr median 0.9
- EV / EBITDA
- 1.3
- Dividend yield
- —
- Beta
- 2.12
LONA key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsLONA valuation Price multiples at each fiscal year-end price.
LONA returns How much profit the business earns on the capital it uses.
LONA per-share figures Results divided by the shares outstanding at year-end.
LONA financial health Debt, liquidity and how easily interest is covered.
LONA efficiency & capital use Working capital cycle and where the cash goes.
LONA valuation history
LONA returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
LONA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
LONA price vs earnings per share
LONA key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $32.4M | $22.6M | $92.4M | $119.6M | $481.1M | $1.11B | — | — |
| Enterprise value | −$55.2M | −$27.5M | −$53.4M | −$78.8M | $229.2M | $929.0M | — | — |
| Price / book | 1.2 | 0.5 | 0.7 | 0.5 | 1.5 | 4.1 | — | — |
| Earnings yield | −326.3% | −429.2% | −127.4% | −80.0% | −11.4% | −1.8% | — | — |
| Free cash flow yield | −141.3% | −430.3% | −109.4% | −61.5% | −9.3% | −2.4% | — | — |
| Share price at fiscal year-end | $7.57 | $5.87 | $24.30 | $31.70 | $130.30 | $342.50 | — | — |
| Per share | ||||||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$24.70 | −$25.19 | −$30.95 | −$25.35 | −$14.86 | −$6.14 | −$1.58 | −$1.56 |
| Operating cash flow per share | −$10.69 | −$25.25 | −$26.50 | −$19.21 | −$11.67 | −$7.42 | −$1.14 | −$1.37 |
| Free cash flow per share | −$10.69 | −$25.26 | −$26.58 | −$19.51 | −$12.10 | −$8.14 | −$1.14 | −$1.37 |
| Cash per share | $20.66 | $13.32 | $38.77 | $53.09 | $68.73 | $56.85 | $0.63 | $1.48 |
| Book value per share | $6.50 | $11.65 | $34.24 | $62.32 | $86.96 | $84.43 | −$6.05 | −$4.56 |
| Tangible book value per share | $6.50 | $11.65 | $34.24 | $62.32 | $86.96 | $84.43 | −$6.05 | −$4.56 |
| Capex per share | $0.00 | $0.01 | $0.08 | $0.30 | $0.43 | $0.71 | $0.00 | $0.00 |
| Debt per share | $0.19 | $0.32 | $0.42 | $0.51 | $0.52 | $0.31 | $0.48 | $0.22 |
| Shares outstanding | 4.3M | 3.8M | 3.8M | 3.8M | 3.7M | 3.2M | 3.3M | 3.3M |
| Change in shares outstanding | +11.1% | +1.2% | +0.8% | +2.2% | +13.7% | −0.4% | 0.0% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −290.8% | −110.8% | −64.4% | −34.4% | −18.4% | −15.7% | — | — |
| Return on invested capital (ROIC) | — | — | — | −155.1% | −63.3% | −44.9% | — | — |
| Return on assets (ROA) | −139.9% | −88.5% | −56.2% | −32.4% | −17.9% | −14.2% | −144.9% | −103.3% |
| Return on tangible assets | −114.6% | −164.9% | −73.4% | −37.0% | −16.5% | −7.1% | −235.8% | −103.3% |
| Financial health | ||||||||
| Total debt | $803,000 | $1.2M | $1.6M | $1.9M | $1.9M | $1.0M | $1.6M | $722,000 |
| Cash & short-term investments | $88.3M | $51.3M | $147.4M | $200.3M | $253.8M | $184.7M | $2.1M | $4.8M |
| Net debt | −$87.5M | −$50.1M | −$145.8M | −$198.4M | −$251.8M | −$183.7M | −$503,000 | −$4.1M |
| Debt / equity | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | — | — |
| Debt / assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.71 | 0.15 |
| Current ratio | 1.88 | 4.18 | 5.37 | 9.68 | 28.07 | 43.66 | 1.70 | 8.56 |
| Quick ratio | 1.88 | 4.18 | 5.37 | 9.74 | 28.07 | 43.66 | 1.70 | 8.56 |
| Interest coverage | — | — | — | -4.3 | — | -54.5 | -15.7 | -556.6 |
| Working capital | $42.0M | $41.7M | $125.9M | $186.1M | $251.5M | $187.9M | $887,000 | $4.3M |
| Invested capital | −$59.7M | −$5.2M | −$15.6M | $36.7M | $69.2M | $90.6M | −$20.2M | −$19.0M |
| Tangible asset value | $27.8M | $44.8M | $130.2M | $235.1M | $321.1M | $274.3M | −$19.7M | −$14.9M |
| Net current asset value | $25.1M | $40.9M | $124.7M | $184.5M | $249.9M | $187.1M | −$19.8M | −$14.9M |
| Graham net-net per share | $5.61 | $9.70 | $31.19 | $47.08 | $66.25 | $55.52 | −$6.09 | −$4.60 |
| Capital allocation | ||||||||
| Capex / depreciation | 0.00 | 0.03 | 0.31 | 1.35 | 3.28 | 9.24 | 0.00 | 0.00 |
| Efficiency | ||||||||
| Days payables outstanding | 13.1 | — | — | — | 657.2 | 144.1 | — | — |
| Receivables turnover | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables turnover | 27.76 | — | — | — | 0.56 | 2.53 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | — | — | $1.4M | $1.8M | $1.8M | $653,500 | $6,500 | $6,000 |
| Average payables | $2.5M | $224,000 | $1.3M | $1.5M | $862,500 | $789,500 | $271,000 | $121,000 |
| Average inventory | — | — | — | −$1.2M | — | — | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from LONA's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
LONA valuation and financial ratios
LeonaBio earned a return on equity of −290.8% in fiscal 2025. It ended the year with $0.8 million of debt and $88.3 million in cash and short-term investments, a net cash position of $87.5 million. The share count rose 31.1% from 3.3M to 4.3M over 7 years.
See the LONA income statement, the LONA chart for price history, or the LONA stock overview for the latest quote and news.
LONA key metrics FAQ
What is LeonaBio's return on equity?
LeonaBio's return on equity (ROE) was −290.8% in fiscal 2025: net income of -$105.6 million on average shareholders' equity of $36.3 million.
How much debt does LeonaBio have?
LeonaBio had total debt of $0.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.03 and more cash than debt.
What is LeonaBio's free cash flow yield?
LeonaBio generated -$45.7 million of free cash flow in fiscal 2025, a free cash flow yield of −141.3% on its market value at year-end ($32.4 million).
What is LeonaBio's current ratio?
LeonaBio's current ratio was 1.88 at the end of fiscal 2025: current assets were 1.88 times current liabilities.